Trial Profile
A Comparative Study of Inhaled Ciclesonide 200 mcg/Day vs Fluticasone Propionate 200 mcg/Day in Children With Asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2016
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca; Takeda
- 04 May 2012 Company (Takeda Global Research and Development Center) added as reported by ClinicalTrials.gov.
- 22 Sep 2006 Status change
- 26 Nov 2005 New trial record.